Frank Fabozzi - BlackRock Science Independent Trustee
BST Etf | USD 36.75 0.16 0.44% |
Mr. Frank J. Fabozzi is Independent Trustee of Blackrock Science And Technology Trust . Frank J. Fabozzi recently joined as a member of the boards of the funds in the EquityLiquidity Complex. Dr. Fabozzi has served for over 25 years on the boards of registered investment companies. Dr. Fabozzi holds the designations of Chartered Financial Analyst and Certified Public Accountant. Dr. Fabozzi was inducted into the Fixed Income Analysts Societys Hall of Fame and is the 2007 recipient of the C. Stewart Sheppard Award given by the CFA Institute. The Board benefits from Dr. Fabozzis experiences as a professor and author in the field of finance. Dr. Fabozzis experience as a Professor of Finance at EDHEC Business School, as a Professor in the Practice of Finance and Becton Fellow at the Yale University School of Management and as editor of the Journal of Portfolio Management demonstrate his wealth of expertise in the investment management and structured finance areas. Dr. Fabozzi has authored and edited numerous books and research papers on topics in investment management and financial econometrics, and his writings have focused on fixed income securities and portfolio management, many of which are considered standard references in the investment management industry. Dr. Fabozzis longstanding service on the boards of the ClosedEnd Complex also provides him with a specific understanding of the Trust, its operations and the business and regulatory issues facing the Trust. Moreover, Dr. Fabozzis knowledge of financial and accounting matters qualifies him to serve as a member of the Trusts Audit Committee. Dr. Fabozzis independence from the Trust and the Advisor enhances his service as Chair of the Performance Oversight Committee and as a member of the Governance and Nominating Committee and Leverage Committee.
Age | 73 |
Tenure | 11 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Frank Fabozzi Latest Insider Activity
Tracking and analyzing the buying and selling activities of Frank Fabozzi against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Frank Fabozzi insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Frank Fabozzi over six months ago Disposition of 158 shares by Frank Fabozzi of BlackRock Floating subject to Rule 16b-3 | ||
Frank Fabozzi over six months ago Disposition of 158 shares by Frank Fabozzi of BlackRock Floating subject to Rule 16b-3 |
Similar Fund Executives
Showing other executives | One Year Return | ||
Larry Papasan | Reaves Utility If | 79 | |
Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
Lisa Phelan | Cohen Steers Total | 51 | |
James Jacobson | Pimco Corporate Income | 75 | |
Michael Holland | Reaves Utility If | 75 | |
Xiang Liu | BlackRock Health Sciences | N/A | |
Charles Park | BlackRock Health Sciences | 58 | |
Joseph Beranek | Columbia Seligman Premium | 55 | |
Thomas Kent | Tekla Healthcare Investors | 67 | |
Jeffrey Lee | BlackRock Health Sciences | N/A | |
Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
Albert Laskaj | Cohen And Steers | 43 | |
Dana Devivo | Cohen Steers Total | 39 | |
Stacie Anctil | Pimco Corporate Income | 51 | |
Valerie Mosley | Eaton Vance Enhanced | 61 | |
Robert Hubbard | BlackRock Health Sciences | 63 | |
Janey Ahn | BlackRock Health Sciences | 46 | |
Erin Xie | BlackRock Health Sciences | 57 | |
Thomas CFA | BlackRock Health Sciences | N/A | |
Christopher Accettella | BlackRock Health Sciences | N/A | |
Lindsay Sinclair | BlackRock Utility Infrastructur | N/A |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.